Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:GAR)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003036 AN004977 Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 2 Bacterial cells Pseudomonas aeruginosa Bacterial infection Monash Institute of Pharmaceutical Sciences LC-MS
ST003020 AN004954 Polar metabolite levels in MEL cells following PKC inhibition in 2,000 nM or 100 nM FA conditions Cultured cells Mouse Anemia Boston Children's Hospital, Harvard Medical School LC-MS
ST003018 AN004952 Polar metabolite levels in K562 cells following PKC inhibition in 2,000 nM or 100 nM FA conditions Cultured cells Human Anemia Boston Children's Hospital, Harvard Medical School LC-MS
ST002913 AN004783 Polar metabolite levels in K562 cells following folate depletion Cultured cells Human Anemia Boston Children's Hospital, Harvard Medical School LC-MS
ST002912 AN004782 Polar metabolite levels in MEL cells following folate depletion Cultured cells Mouse Anemia Boston Children's Hospital, Harvard Medical School LC-MS
ST002906 AN004769 Polar metabolite levels in K562 cells following short-term folate depletion Cultured cells Human Anemia Boston Children's Hospital, Harvard Medical School LC-MS
ST002898 AN004757 Polar metabolite levels in MEL cells following folate depletion, SHIN1 or AICAR treatment Cultured cells Mouse Anemia Boston Children's Hospital, Harvard Medical School LC-MS
ST002897 AN004756 Polar metabolite levels in K562 cells following folate depletion, SHIN1 or AICAR treatment Cultured cells Human Anemia Boston Children's Hospital, Harvard Medical School LC-MS
ST002896 AN004755 Polar metabolite levels in MEL cells following folate depletion and inosine supplementation Cultured cells Mouse Anemia Boston Children's Hospital, Harvard Medical School LC-MS
ST002895 AN004754 Polar metabolite levels in K562 cells following folate depletion and inosine supplementation Cultured cells Human Anemia Boston Children's Hospital, Harvard Medical School LC-MS
ST002878 AN004716 Atlas of fetal metabolism during mid-to-late gestation and diabetic pregnancy. Dynamic Labelling experiment. Embryonic cells Mouse Diabetes University of California, Los Angeles LC-MS
ST002852 AN004673 MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer Prostate Mouse Cancer University of California, Los Angeles LC-MS
ST002831 AN004624 Folate depletion upregulates heme synthesis Cultured cells Human Anemia Boston Children's Hospital, Harvard Medical School LC-MS
ST002814 AN004706 Atlas of fetal metabolism during mid-to-late gestation and diabetic pregnancy Embryonic cells Mouse Diabetes University of California, Los Angeles LC-MS
ST002709 AN004391 FH variant pathogenicity promotes purine salvage pathway dependence in kidney cancer Cultured cells Human Cancer University of California, Los Angeles LC-MS
ST002708 AN004390 Levels of central carbon metabolites in choroid plexus as part of natural diurnal variation Brain Mouse Circadian Rhythm Disorder Boston Children's Hospital LC-MS
ST002477 AN004046 Neutrophil metabolomics in COVID-19 Neutrophils Human COVID-19 UT Southwestern Medical Center LC-MS
ST002371 AN003866 High-resolution metabolomics analysis of NLRP3 inflammasome activated macrophages Macrophages Mouse Inflammation Wake Forest School of Medicine GC-MS
ST002119 AN003468 Metabolomics analysis of zebrafish response to CID661578 treatment Larvae Zebrafish Diabetes North Carolina State University LC-MS
ST001974 AN003222 Anti-oxidative metabolism measurement in mammalian cells and tissues by quantitative LC/MS method (I) Cerebrospinal fluid Mouse Cancer Boston Children's Hospital, Harvard Medical School LC-MS
ST001954 AN003179 A pathogenic role for histone H3 copper reductase activity in a yeast model of Friedreich’s Ataxia Yeast cells Yeast Friedreichs Ataxia University of California, Los Angeles LC-MS
ST001772 AN002879 Optimization of redox metabolite detection in mammalian cells (part II) Cultured cells Human Boston Children's Hospital, Harvard Medical School LC-MS
ST001771 AN002878 Application of the redox metabolite detection method for profiling redox state following pharmacologic perturbations of redox balance in cells (part III) Cultured cells Human Boston Children's Hospital, Harvard Medical School LC-MS
ST001770 AN002877 Application of the redox metabolite detection method for profiling redox state following pharmacologic perturbations of redox balance in cells (part II) Cultured cells Human Boston Children's Hospital, Harvard Medical School LC-MS
ST001769 AN002876 Application of the redox metabolite detection method for profiling redox state following pharmacologic perturbations of redox balance in cells (part I) Cultured cells Human Boston Children's Hospital, Harvard Medical School LC-MS
ST001765 AN002872 Optimization of redox metabolite detection in mammalian cells (part I) Cultured cells Human Boston Children's Hospital, Harvard Medical School LC-MS
ST001764 AN002871 Application of the redox metabolite detection method for profiling redox state following pharmacologic perturbation with methotrexate Cultured cells Human Boston Children's Hospital, Harvard Medical School LC-MS
ST001763 AN002870 Application of the redox metabolite detection method for mouse liver (part II) Liver Mouse Boston Children's Hospital, Harvard Medical School LC-MS
ST001762 AN002869 Application of the redox metabolite detection method for mouse kidney (part II) Kidney Mouse Boston Children's Hospital, Harvard Medical School LC-MS
ST001759 AN002866 Application of the redox metabolite detection method for mouse liver Liver Mouse Boston Children's Hospital, Harvard Medical School LC-MS
ST001611 AN002646 Mouse model of sarcoma (STS) to characterize tumor vulnerabilities and identify novel targets for anti-cancer treatment Muscle Mouse Cancer North Carolina State University LC-MS
ST001611 AN002646 Mouse model of sarcoma (STS) to characterize tumor vulnerabilities and identify novel targets for anti-cancer treatment Sarcoma Mouse Cancer North Carolina State University LC-MS
ST001610 AN002644 Control (DMSO 0.1%; v/v) and 10 µM DRB18 treated A549 lung cancer cells in vitro for 48 hours Lung Human Cancer Ohio University LC-MS
ST001549 AN002580 β-Adrenergic regulation of metabolism in macrophages (part-III) Macrophages Human Monash University LC-MS
  logo